Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optive vs Hylocomod in Dry Eye
NCT00761202Phase 4Completed
- Sponsor
- Allergan
- Start
- Aug 2007
- Primary completion
- Jun 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carboxymethylcellulose sodium + glycerin in dry eye syndrome (DED), sponsored by Allergan. Started Aug 2007; status: completed.
02
Drugs
carboxymethylcellulose sodium + glycerin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT00761202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00761202.